These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11059766)

  • 1. Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue.
    Brand K; Baker AH; Perez-Cantó A; Possling A; Sacharjat M; Geheeb M; Arnold W
    Cancer Res; 2000 Oct; 60(20):5723-30. PubMed ID: 11059766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis.
    Elezkurtaj S; Kopitz C; Baker AH; Perez-Cantó A; Arlt MJ; Khokha R; Gansbacher B; Anton M; Brand K; Krüger A
    J Gene Med; 2004 Nov; 6(11):1228-37. PubMed ID: 15390257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
    J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
    Bendrik C; Robertson J; Gauldie J; Dabrosin C
    Cancer Res; 2008 May; 68(9):3405-12. PubMed ID: 18451168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivo.
    Rigg AS; Lemoine NR
    Cancer Gene Ther; 2001 Nov; 8(11):869-78. PubMed ID: 11773977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
    Ishizaki T; Katsumata K; Tsuchida A; Wada T; Mori Y; Hisada M; Kawakita H; Aoki T
    Int J Mol Med; 2006 Feb; 17(2):357-62. PubMed ID: 16391837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer].
    Yang Q; Yang G; Wei L; Jia F; Wu M; Guo Y
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):775-9. PubMed ID: 12126551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.
    Heideman DA; van Beusechem VW; Bloemena E; Snijders PJ; Craanen ME; Offerhaus GJ; Derksen PW; de Bruin M; Witlox MA; Molenaar B; Meijer CJ; Gerritsen WR
    J Gene Med; 2004 Mar; 6(3):317-27. PubMed ID: 15026993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.
    Lamfers ML; Gianni D; Tung CH; Idema S; Schagen FH; Carette JE; Quax PH; Van Beusechem VW; Vandertop WP; Dirven CM; Chiocca EA; Gerritsen WR
    Cancer Res; 2005 Oct; 65(20):9398-405. PubMed ID: 16230403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.
    Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A
    Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.
    Lin T; Gu J; Zhang L; Huang X; Stephens LC; Curley SA; Fang B
    Cancer Res; 2002 Jul; 62(13):3620-5. PubMed ID: 12097263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of colorectal cancer liver metastasis and extension of survival by expression of apolipoprotein(a) kringles.
    Yu HK; Kim JS; Lee HJ; Ahn JH; Lee SK; Hong SW; Yoon Y
    Cancer Res; 2004 Oct; 64(19):7092-8. PubMed ID: 15466205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
    Collins HM; Morris TM; Watson SA
    Br J Cancer; 2001 Jun; 84(12):1664-70. PubMed ID: 11401321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial delivery of a recombinant adenovirus does not increase gene transfer to tumor cells in a rat model of metastatic colorectal carcinoma.
    Maron DJ; Tada H; Moscioni AD; Tazelaar J; Fraker DL; Wilson JM; Spitz FR
    Mol Ther; 2001 Jul; 4(1):29-35. PubMed ID: 11472103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3.
    Tran PL; Vigneron JP; Pericat D; Dubois S; Cazals D; Hervy M; DeClerck YA; Degott C; Auclair C
    Cancer Gene Ther; 2003 Jun; 10(6):435-44. PubMed ID: 12768188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin.
    Dong YB; Yang HL; McMasters KM
    Cancer Gene Ther; 2003 Mar; 10(3):168-78. PubMed ID: 12637937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
    Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation.
    Rupertus K; Dahlem C; Menger MD; Schilling MK; Kollmar O
    Ann Surg Oncol; 2009 Sep; 16(9):2629-37. PubMed ID: 19551445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis.
    Bloomston M; Shafii A; Zervos EE; Rosemurgy AS
    J Surg Res; 2002 Jan; 102(1):39-44. PubMed ID: 11792150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.